However, multiple pluripotency markers, such as CD44, CD117 and Oct3/4, have been shown to be expressed in prostate cancer, indicating that prostate cancer may develop from common stem cell-like or intermediate cells (8,44). This evidence concerns the gene KIT and Familial prostate cancer.